Priority Considerations for Medicinal Cannabis-Related Research
2019; Mary Ann Liebert, Inc.; Volume: 4; Issue: 3 Linguagem: Inglês
10.1089/can.2019.0045
ISSN2578-5125
AutoresMarcel O. Bonn‐Miller, Charles V. Pollack, David Casarett, Richard C. Dart, Mahmoud A. ElSohly, Larry Good, Manuel Guzmán, L Hanŭs, Kevin P. Hill, Marilyn A. Huestis, Eric D. Marsh, Susan Sisley, Nancy Skinner, Judith Spahr, Ryan G. Vandrey, Eugene R. Viscusi, Mark A. Ware, Donald I. Abrams,
Tópico(s)Sleep and Wakefulness Research
ResumoCannabis and Cannabinoid ResearchVol. 4, No. 3 PerspectivePriority Considerations for Medicinal Cannabis-Related ResearchMarcel O. Bonn-Miller, Charles V. Pollack Jr., David Casarett, Richard Dart, Mahmoud ElSohly, Larry Good, Manuel Guzmán, Lumír Hanuš, Kevin P. Hill, Marilyn A. Huestis, Eric Marsh, Susan Sisley, Nancy Skinner, Judith Spahr, Ryan Vandrey, Eugene Viscusi, Mark A. Ware, and Donald AbramsMarcel O. Bonn-Miller*Address correspondence to: Marcel O. Bonn-Miller, PhD, Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, 3535 Market Street, Suite 500, Philadelphia, PA 19104 E-mail Address: mbonnmil@gmail.comDepartment of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.Search for more papers by this author, Charles V. Pollack Jr.Department of Emergency Medicine, Lewis Katz School of Medicine, Temple University, Philadelphia, Pennsylvania.Search for more papers by this author, David CasarettDepartment of Medicine, Duke University School of Medicine, Durham, North Carolina.Search for more papers by this author, Richard DartRocky Mountain Drug and Poison Control Center, Denver, Colorado.Search for more papers by this author, Mahmoud ElSohlyNational Center for Natural Products Research, School of Pharmacy, University of Mississippi, Oxford, Mississippi.Search for more papers by this author, Larry GoodDepartment of Medicine, State University of New York at Stony Brook, Stony Brook, New York.Search for more papers by this author, Manuel GuzmánDepartment of Biochemistry and Molecular Biology, Complutense University of Madrid, Madrid, Spain.Search for more papers by this author, Lumír HanušDepartment of Medicinal and Natural Products, Institute for Drug Research, The Hadassah Medical School, Hebrew University of Jerusalem, Jerusalem, Israel.Search for more papers by this author, Kevin P. HillDepartment of Psychiatry, Harvard Medical School, Boston, Massachusetts.Search for more papers by this author, Marilyn A. HuestisInstitute of Emerging Health Professions, Thomas Jefferson University, Philadelphia, Pennsylvania.Search for more papers by this author, Eric MarshDepartments of Neurology and Pediatrics, Division of Child Neurology, Children's Hospital of Philadelphia and the Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania.Search for more papers by this author, Susan SisleyColorado State University-Pueblo, Pueblo, Colorado.Search for more papers by this author, Nancy SkinnerUniversity of Southern Indiana, Evansville, Indiana.Search for more papers by this author, Judith SpahrLewes, Delaware.Search for more papers by this author, Ryan VandreyBehavioral Pharmacology Research Unit, Johns Hopkins University School of Medicine, Baltimore, Maryland.Search for more papers by this author, Eugene ViscusiInstitute of Emerging Health Professions, Thomas Jefferson University, Philadelphia, Pennsylvania.Search for more papers by this author, Mark A. WareDepartment of Family Medicine, McGill University, Montreal, Quebec, Canada.Search for more papers by this author, and Donald AbramsUCSF Osher Center for Integrative Medicine, University of California-San Francisco, San Francisco, California.Search for more papers by this authorPublished Online:23 Sep 2019https://doi.org/10.1089/can.2019.0045AboutSectionsView articleView Full TextPDF/EPUB Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail View articleFiguresReferencesRelatedDetailsCited bySafety assessment and redox status in rats after chronic exposure to cannabidiol and cannabigerolToxicology, Vol. 488UK Medical Cannabis Registry: A Patient Evaluation10 February 2023 | Journal of Pain & Palliative Care PharmacotherapySafety and Efficacy of the Therapeutic Use of Cannabis-Based Products in the Treatment of Dogs: An Integrative Review Diego Fontana de Andrade, João Lourenço Hasckel Gewehr, and Erik Amazonas de Almeida5 December 2022 | Cannabis and Cannabinoid Research, Vol. 7, No. 6Cannabis dosing and administration for sleep: a systematic review15 September 2022 | Sleep, Vol. 45, No. 11Online survey of medicinal cannabis users: Qualitative analysis of patient-level data6 September 2022 | Frontiers in Pharmacology, Vol. 13Changes in striatal dopamine release, sleep, and behavior during spontaneous Δ-9-tetrahydrocannabinol abstinence in male and female mice27 April 2022 | Neuropsychopharmacology, Vol. 47, No. 8Integrated Medical Cannabis Consultations in a Palliative Care Program: Policies, Procedures, and Progress after Six Years of Practice David Lazris, Dhruv Gaur, Kimberly Curseen, Dio Kavalieratos, Meredith Maxwell, Tammie Quest, and Ali John Zarrabi20 April 2022 | Journal of Palliative Medicine, Vol. 25, No. 5Chronic pain and medical cannabis: Narrative review and practice considerations in persons living with HIV3 January 2022 | JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY, Vol. 5, No. 3A Large-Scale Naturalistic Examination of the Acute Effects of Cannabis on Pain Carrie Cuttler, Emily M. LaFrance, and Rebecca M. Craft10 February 2022 | Cannabis and Cannabinoid Research, Vol. 7, No. 1Cannabis use, abuse, and withdrawal: Cannabinergic mechanisms, clinical, and preclinical findings16 May 2021 | Journal of Neurochemistry, Vol. 46Antioxidant function of phytocannabinoids: Molecular basis of their stability and cytoprotective properties under UV-irradiationFree Radical Biology and Medicine, Vol. 164Short and Long-Term Effects of Cannabis on Symptoms of Post-Traumatic Stress DisorderJournal of Affective Disorders, Vol. 274Terpenes/Terpenoids in Cannabis: Are They Important?10 August 2020 | Medical Cannabis and Cannabinoids, Vol. 3, No. 1Cannabinoids, Endocannabinoids and Sleep22 July 2020 | Frontiers in Molecular Neuroscience, Vol. 13Pharmacodynamic effects of vaporized and oral cannabidiol (CBD) and vaporized CBD-dominant cannabis in infrequent cannabis usersDrug and Alcohol Dependence, Vol. 211 Safety Considerations in Cannabinoid-Based Medicine 1 December 2020 | International Journal of General Medicine, Vol. Volume 13 Volume 4Issue 3Sep 2019 InformationCopyright 2019, Mary Ann Liebert, Inc., publishersTo cite this article:Marcel O. Bonn-Miller, Charles V. Pollack Jr., David Casarett, Richard Dart, Mahmoud ElSohly, Larry Good, Manuel Guzmán, Lumír Hanuš, Kevin P. Hill, Marilyn A. Huestis, Eric Marsh, Susan Sisley, Nancy Skinner, Judith Spahr, Ryan Vandrey, Eugene Viscusi, Mark A. Ware, and Donald Abrams.Priority Considerations for Medicinal Cannabis-Related Research.Cannabis and Cannabinoid Research.Sep 2019.139-157.http://doi.org/10.1089/can.2019.0045Published in Volume: 4 Issue 3: September 23, 2019Online Ahead of Print:August 21, 2019Keywordsmedicinal cannabismedical marijuanaPDF download
Referência(s)